Neuronal loss and β-amyloid removal in the amygdala of people with Down syndrome

Neurobiology of Aging

Volumn 20, Issue 3, 1999, Pages 259-269

  Wȩgiel, Jerzy ^a   Wísniewski, Henryk M ^a   Moryś, Janusz ^b   Tarnawski, Michal ^a   Kuchna, Izabela ^a   Dziewiatkowski, Jerzy ^b   Pirttilä, Tuula ^c   Krivimäki, Tarmo ^d   Lehtimäki, Terho ^e   Lach, Boleslaw ^f  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d Ylinen Ctrl Inst in Pirkanmaa S   (Finland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

^f UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Alzheimer disease; Amygdala; Amyloidosis beta; Down syndrome; Morphometry; Neurofibrillary degeneration

Indexed keywords

AMYLOID BETA PROTEIN;

ADULT; AGED; AGING; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; AMYLOIDOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; HUMAN; MORPHOMETRICS; NERVE DEGENERATION; NEUROFILAMENT; NEUROPATHOLOGY; PRIORITY JOURNAL; REGRESSION ANALYSIS;

ADULT; AGED; AMYGDALA; AMYLOID BETA-PROTEIN; APOLIPOPROTEINS E; CELL COUNT; DOWN SYNDROME; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE DEGENERATION; NEUROFIBRILLARY TANGLES; NEURONS; ORGAN SIZE; PHENOTYPE; REGRESSION ANALYSIS; TAU PROTEINS;

EID: 0033133451     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(99)00060-3     Document Type: Article

References (97)

1. Amaral D.G., Veazey R.B., Cowan W.M. Some observations on hypothalamo-amygdaloid connections in the monkey. Brain Res. 252:1982;13-27.
2. Amaral D.G. Amygdalohippocampal and amygdalocortical projections in the primate brain. Schwarcz R., Ben-Ari Y. Excitatory amino acids and epilepsy. 1986;3-17 Plenum Press, New York.
3. Andersen R. Cognitive changes after amygdalotomy. Neuropsychologica. 16:1976;439-451.
4. Armstrong R.A. β-amyloid plaques stages in life history or independent origin . Dement Geriatr Cogn Disord. 9:1998;227-238.
5. Arriagada P.V., Growdon J.H., Headley-Whyte E.T., Hyman B.T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 42:1992;631-639.
6. Bancher C., Brunner C., Lassmann H., Budka H., Jellinger K., Wiche G., Seitelberger F., Grundke-Iqbal I., Iqbal K., Wisniewski H. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res. 477:1989;90-99.
7. Beaulieu S., Di Paolo R., Cote J., Barden N. Participation of the central amygdaloid nucleus in the response of adrenocorticotropin (ACTH) secretion to immobilization stress opposing roles of the noradrenergic and dopaminergic systems . Neuroendocrinology. 45:1986;37-46.
8. Bobinski M., Wegiel J., Tarnawski M., Bobinski M., Reisberg B., de Leon M.J., Miller D.C., Wisniewski H.M. Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease. J Neuropathol Exp Neurol. 56:1997;414-420.
9. Bobinski M., Wegiel J., Tarnawski M., Bobinski M., de Leon M.J., Reisberg B., Miller D.C., Wisniewski H.M. Duration of neurofibrillary changes in the hippocampal pyramidal neurons. Brain Res. 799:1998;156-158.
10. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 82:1991;239-259.
11. Braak H., Braak E. Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol. 1:1991;213-216.
12. Brady D.R., Mufson E.J. Amygdaloid pathology in Alzheimer's disease qualitative and quantitative analysis . Dementia. 1:1990;5-17.
13. Brashear H.R., Godec M.S., Carlsen J. The distribution of neuritic plaques and acetylcholinesterase staining in the amygdala in Alzheimer's disease. Neurology. 38:1988;1694-1699.
14. Brioni J.D., Nagahara A.H., McGaugh J.L. Involvement of the amygdala GABAergic system in the modulation of memory storage. Brain Res. 487:1988;105-112.
15. Brockhaus H. Zur normalen und pathologishe Anatomie des Mandelkerngebietes. J Psychol Neurol. 49:1938;1-136.
16. Brousseau T., Legrain S., Berr C., Gourlet V., Vidal O., Amouyel P. Confirmation of the ε4 allele of the apolipoprotein E gene as a risk factor for late onset Alzheimer's disease. Neurology. 44:1994;342-344.
17. Brothers L., Ring B., Kling A. Response of neurons in the macaque amygdala to complex social stimuli. Behav Brain Res. 41:1990;199-213.
18. Cork L.C., Masters C., Beyreuther K., Price D.L. Development of senile plaques. Relationships of neuronal abnormalities and amyloid deposits. Am J Pathol. 137:1990;1383-1392.
19. Dickson D.W., Farlo J., Davies P. Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques. Am J Pathol. 132:1988;86-101.
20. Funato H., Yoshimura M., Yamazaki T., Saido T.C., Ito Y., Yokofujita J., Okeda R., Ihara Y. Astrocytes containing amyloid β-protein (Aβ)-positive granules are associated with Aβ40-positive diffuse plaques in the aged human brain. Am J Pathol. 152:1998;983-992.
21. Gaffan D., Gaffan E.A., Harrison S. Visual-visual associative memory and reward association learning in monkeys the role of the amygdala . J Neurosci. 9:1989;558-564.
22. Goedert M., Spillantini M., Jakes R., Rutherford D., Crowther R. Multiple isoforms of human microtubule-associated protein tau sequences and localization in neurofibrillary tangles of Alzheimer's disease . Neuron. 3:1989;519-526.
23. Gomez-Isla T., Price J.L., McKeel D.W. Jr, Morris J.C., Growdon J.H., Hyman B.T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci. 16:1996;4491-4500.
24. Haass C., Schlossmacher M.G., Hung A.Y., Vigo-Pelfry C., Mellon A., Ostaszewski B.L., Lieberburg I., Koo E.H., Schenk D., Teplow D.B., Selkoe D.J. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature. 359:1992;322-325.
25. Henke P.G. Hippocampal pathway to the amygdala and stress ulcer development. Br Res Bull. 25:1990;691-695.
26. Hedreen J.C., Broadhead J.C., Price D.L. Senile plaques in the amygdala in Alzheimer's disease. Neurology. 38:(suppl.):1988;227.
27. Herzog A.G., Kemper T.L. Amygdaloid changes in aging and dementia. Arch Neurol. 37:1980;625-629.
28. Hooper M.W., Vogel F.S. The limbic system in Alzheimer's disease neuropathologic investigation . Am J Pathol. 85:1976;1-20.
29. Hyman B.T., Marzloff K., Arriagada P.V. The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution. J Neuropathol Exp Neurol. 52:1993;594-600.
30. Hyman B.T., van Hoesen G.W., Damasio A.R. Memory-related neural systems in Alzheimer's disease. An anatomic study. Neurology. 40:1990;1721-1730.
31. Hyman B.T., Tanzi R.E. Amyloid, dementia and Alzheimer's disease. Curr Opin Neurol Neurosurg. 5:1992;88-93.
32. Jamada M., Mehraein P. Verteilungsmuster der senilen Veranderungen in Gehirn. Arch Psychiatr Nervenkr. 211:1968;308-324.
33. Kaada B. Stimulation and regional ablation of the amygdaloid complex with reference to functional representation. Eleftheriou B.E. The neurobiology of the amygdala. 1972;145-204 Plenum Press, New York.
34. Katzman R., Terry R., De Teresa R., Brown T., Davies P., Fuld P., Renbing X., Peck A. Clinical, pathological, neurochemical changes in dementia a subgroup with preserved mental status and numerous neocortical plaques . Ann Neurol. 23:1988;138-144.
35. Kemper T.L. Organization of the neuropathology of the amygdala in Alzheimer's disease. Katzman R. Biological aspects of Alzheimer's disease. 1984;31-35 Cold Spring Harbor Laboratory, New York.
36. Kim K., Miller D., Sapienza V., Chen C., Bai C., Grundke-Iqbal I., Currie J., Wisniewski H. Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci Res Commun. 2:1988;121-130.
37. Kitamoto T., Ogomori K., Tateishi J., Prusiner S. Methods in laboratory investigation. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest. 57:1987;230-236.
38. Kromer Vogt L.J., Hyman B.T., van Hoesen G.W., Damasio A.R. Pathological alterations in the amygdala in Alzheimer's disease. Neuroscience. 37:1990;377-385.
39. Lehtimaki T., Pirttila T., Mehta P.D., Wisniewski H.M., Frey H., Nikkari T. Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentration in the cerebrospinal fluid in Finnish patients with Alzheimer's disease. Hum Genet. 95:1995;39-42.
40. Leuba G., Kraftsik R., Saini K. Quantitative distribution of parvalbumin, calretinin, and Calbindin D-28k immunoreactive neurons in the visual cortex of normal and Alzheimer cases. Exp Neurol. 152:1998;278-291.
41. Mahley R.W. Apolipoprotein E cholesterol transport protein with expanding role in cell biology . Science. 240:1988;622-630.
42. Mandybur T.I. Cerebral amyloid angiopathy and astrocytic gliosis in Alzheimer's disease. Acta Neuropathol. 78:1989;329-331.
43. Mann D.M.A., Esiri M.M. The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J Neurol Sci. 89:1989;169-179.
44. Mann D.M.A., Yates P.O., Marcyniuk B., Ravindra C.R. The topography of plaques and tangles in Down's syndrome patients of different ages. Neuropathol Appl Neurobiol. 12:1986;447-457.
45. Markowitsch H.J. The amygdala's role in human mnemonic processing. Cortex. 1:1985;7-24.
46. McGaugh J.L., Introinin-Collison I.B., Nagahara A.H., Cahill L., Brioni J.D., Castellano C. Involvement of the amygdaloid complex in neuromodulatory influences on memory storage. Neurosci Biobehav Rev. 14:1990;425-431.
47. Mehler W.R. Subcortical afferent connections of the amygdala in the monkey. J Comp Neurol. 190:1980;733-762.
48. Mesulam M., Geula C. Nucleus basalis (Ch4) and cortical cholinergic innervation of the human brain observations based on the distribution of acetylcholinesterase and choline acetyltransferse . J Comp Neurol. 275:1988;216-240.
49. Mirra S.S., Hart M., Terry R.D. Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists. Arch Pathol Lab Med. 117:1993;132-144.
50. Morris J.C., McKeel D.W., Storandt M. Very mild Alzheimer's disease informant-based clinical, psychometric, and pathologic distinction from normal aging . Neurology. 41:1991;469-478.
51. Murphy G.M., Inger P., Mark K., Lin J., Morrice W., Gee C., Gan S., Korp B. Volumetric asymmetry in the human amygdaloid complex. J Hirnforsch. 28:1987;281-289.
52. Murphy G.M., Ellis W.G. The amygdala in Down's syndrome and familial Alzheimer's disease four clinicopathological case reports . Biol Psychiatry. 30:1991;92-106.
53. Neary D., Snowden J.S., Mann D.M.A., Bowen D.M., Simms N.R., Northen B., Yates P.O., Davison A.N. Alzheimer's disease a correlative study . J Neurol Neurosurg Psychiatry. 49:1986;229-237.
54. Ohm T.G., Muller H., Braak H., Bohl J. Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes. Neuroscience. 64:1995;209-217.
55. Pakkenberg B., Gundersen H.J.G. Total number of neurons and glial cells in human brain nuclei estimated by the disector and fractionator. J Microsc. 150:1988;1-20.
56. Pappolla M.A., Omar R.A., Vinters H.V. Image analysis microspectroscopy shows that neurons participate in the genesis of a subset of early primitive (diffuse) senile plaques. Am J Pathol. 39:1991;599-607.
57. Peacock M.L., Fink J.K. ApoE ε4 allelic association with Alzheimer's disease independent confirmation using denaturing gradient gel electrophoresis . Neurology. 44:1994;339-341.
58. Price J.L., Amaral D.G. An autoradiographic study of the projections of the central nucleus of the monkey amygdala. J Neurosci. 11:1981;1242-1249.
59. Price J.L., Davis P.B., Morris J.C., White D.L. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging. 12:1991;295-312.
60. Price L.P., Thinkaran G., Borchelt D.R., Martin L.J., Crain B.J., Sisodia S.S., Troncosos J.C. Neuropathology of Alzheimer's disease and animal models. Markesbery W.R. Neuropathology of dementing disorders. 1998;121-141 Arnold, London.
61. Probst A., Langui D., Ipsen S., Robakis N., Ulrich J. Deposition of beta/A4 protein along neuronal plasma membranes in diffuse senile plaques. Acta Neuropathol. 83:1991;21-29.
62. Rebeck G.W., Reiter J.S., Strickland D.K., Hyman B.T. Apolipoprotein E in sporadic Alzheimer's disease allelic variation and receptor interactions . Neuron. 11:1993;575-580.
63. Reisberg B. Functional assessment staging (FAST). Psychopharmacol Bull. 24:1988;653-659.
64. Reisberg B., Ferris S.H., De Leon M.J., Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 139:1982;1136-1139.
65. Russchen F.T. Cortical and subcortical afferents of the amygdaloid complex. Schwarcz R., Ben Ari Y. Excitatory amino acids and epilepsy. 1986;35-52 Plenum Press, New York.
66. Sadowski M., Wisniewski H.M., Tarnawski M., Kozlowski P.B., Lach B., Wegiel J. Entorhinal cortex of aged subjects with Down syndrome shows severe neuronal loss caused by neurofibrillary pathology. Acta Neuropathol. 97:1999;156-164.
67. Saunders R.C., Rosene D.L. A comparison of the efferents of the amygdala and the hippocampal formation in the rhesus monkey I. Convergence in the entorhinal, prorhinal and perirhinal cortices . J Comp Neurol. 271:1988;153-184.
68. Saunders R.C., Rosene D.L., Van Hoesen G.W. Comparison of the efferents of the amygdala and the hippocampal formation in the rhesus monkey II. Reciprocal and non-reciprocal connections . J Comp Neurol. 271:1988;185-207.
69. Schechter R., Yen S.H.C., Terry R.D. Fibrous astrocytes in senile dementia of Alzheimer type. J Neuropathol Exp Neurol. 40:1981;95-101.
70. Schmechel D.E., Saunders A.M., Strittmatter W.J., Crain B.J., Hulette C.M., Joo S.H., Pericak-Vance M.A., Goldgaber D., Roses A.D. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA. 90:1993;9649-9653.
71. Schochet S.S. Jr, Lampert P.W., McCormick W.F. Neurofibrillary tangles in patients with Down's syndrome a light and electron microscopic study . Acta Neuropathol. 23:1973;342-346.
72. Scott S.A., DeKosky S.T., Scheff S.W. Volumetric atrophy of the amygdala in Alzheimer's disease quantitative serial reconstruction . Neurology. 41:1991;351-356.
73. Scott S.A., DeKosky S.T., Sparks L., Knox C.A., Scheff S.W. Amygdala cell loss and atrophy in Alzheimer's disease. Ann Neurol. 32:1992;555-563.
74. Shoji M., Golde T.E., Ghiso J., Cheung T.T., Estus S., Shaffer L.M., Cai X.-D., McKay D.M., Tintner R., Frangione B., Younkin S.G. Production of Alzheimer amyloid β protein by normal proteolytic processing. Science. 258:1992;126-129.
75. Silverman W., Wisniewski H.M., Bobinski M., Wegiel J. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging. 18:1997;377-379.
76. Sims K.S., Williams R.S. The human amygdaloid complex a cytologic and histochemical atlas using Nissl, myelin, acetylcholinesterase and nicotinamide adenine dinucleotide phosphate diaphorase staining . Neuroscience. 36:1990;449-472.
77. Sterio D.C. The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microscopy. 134:1984;127-136.
78. Strittmatter W., Weisgraber K.W., Huang D.Y., Dong L.-M., Salvesen G.S., Pericak-Vance M., Schmechel D., Saunders A.M., Goldgaber D., Roses A.D. Binding of human apolipoprotein E to synthetic amyloid β peptide isoform-specific effects and implications for late-onset Alzheimer disease . Proc Natl Acad Sci USA. 90:1993;8098-8102.
79. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hanse L.A., Katzman R. Physical bases of cognitive alteration in Alzheimer's disease synaptic loss is the major correlate of cognitive impairment . Ann Neurol. 30:1991;572-580.
80. Tranel D., Hyman B.T. Neuropsychological correlations of bilateral amygdala damage. Arch Neurol. 47:1990;349-355.
81. Unger J., McNeill T.H., Lapham L.L., Hamill R.W. Neuropeptides and neuropathology in the amygdala in Alzheimer's disease relationship between somatostatin, neuropeptide Y and subregional distribution of neuritic plaques . Brain Res. 452:1988;293-302.
82. Vereecken Th.H.L.G., Vogels O.J.M., Nieuwenhuys R. Neuron loss and shrinkage in the amygdala in Alzheimer's disease. Neurobiol Aging. 15:1994;45-54.
83. Wegiel J., Wisniewski H.M. The complex of microglial cells and amyloid star in three-dimensional reconstruction. Acta Neuropathol. 81:1990;116-124.
84. Wegiel J., Wisniewski H.M., Dziewiatkowski J., Tarnawski M., Nowakowski J., Dziewiatkowska A., Soltysiak Z. The origin of amyloid in cerebral vessels of aged dogs. Brain Res. 705:1995;225-234.
85. Wegiel J., Wisniewski H.M. Projections of neurons in neuritic plaques formation. Neuroscience News. 2:1999;34-39.
86. Wegiel J., Wisniewski H.M. Astrocyte pathology in Alzheimer disease. Schipper H.M. Astrocytes in brain aging. Neuroscience intelligence unit 3. 1998;91-109 R.G. Landes Co, Austin, TX.
87. West M.J. New stereological methods for counting neurons. Neurobiol Aging. 14:1993;275-285.
88. Wisniewski H.M., Wegiel J., Wang K.C., Kujawa M., Lach B. Ultrastructural studies of the cells forming amyloid fibers in classical plaques. Can J Neurol Sci. 16:1989;535-542.
89. Wisniewski H.M., Wegiel J. Spatial relationships between astrocytes and classical plaque components. Neurobiol Aging. 12:1991;593-600.
90. Wisniewski H.M., Wegiel J. β-amyloid formation by myocytes of leptomeningeal vessels. Acta Neuropathol. 87:1994;233-241.
91. Wisniewski H.M., Wegiel J., Popovitch E.R. Age-associated development of diffuse and thioflavine-S-positive plaques in Down syndrome. Dev Brain Dysfunct. 7:1994;330-339.
92. Wisniewski H.M., Wegiel J., Kotula L. Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines. Neuropathol Appl Neurobiol. 22:1996;3-11.
93. Wisniewski H.M., Sadowski M., Jakubowska-Sadowska K., Tarnawski M., Wegiel J. Diffuse, lake-like amyloid-β deposits in the parvopyramidal layer of the presubiculum in Alzheimer disease. J Neuropathol Exp Neurol. 57:1998;674-683.
94. Wisniewski H.M., Wegiel J., Wisniewski T. Pathogenesis of amyloid-β plaques Activated microglia the cause of fibrillar amyloid formation and neuropil degeneration . NeuroScience News. 1:1998;30-34.
95. Wisniewski K.E., Dalton A.J., Crapper McLachlan D.R., Wen G.Y., Wisniewski H.M. Alzheimer's disease in Down's syndrome clinicopathological studies . Neurology. 35:1985;957-961.
96. Wisniewski K.E., Wisniewski H.M., Wen G.Y. Occurrence of neuropathologic changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol. 17:1985;278-282.
97. Yamaguchi H., Sugihara S., Ogawa A., Saido T.C., Ihara Y. Diffuse plaques associated with astroglial amyloid β protein, possibly showing a disappearing stage of senile plaques. Acta Neuropathol. 95:1998;217-222.